Severe Asthma Spotlight-Ask the Experts: Biologics in Airway Disorders

Video Transcription

Video Summary

In this video, a panel of experts discuss the use of biologics in airway disorders, with a specific focus on asthma. They cover various topics related to biologics, including eligibility criteria, effectiveness, and safety. The session starts with an overview of the topics to be discussed, and the format of the session, which includes both presentations and audience questions. The speakers discuss different biologics that target specific pathways involved in airway inflammation, such as IgE, IL-4, IL-13, IL-5, and TSLP. They provide information on the eligibility criteria for these biologics, as well as the evidence of their use in asthma and other airway disorders. They also discuss the predictors of good response to biologics, such as high eosinophil levels and disease severity. The speakers emphasize the importance of long-term efficacy and safety of biologics, and highlight ongoing studies to determine the efficacy of these agents in other airway disorders, such as COPD. They also touch on the challenges of navigating insurance coverage for biologics, and the disparities in access to these medications. Overall, the panel provides valuable insights into the use of biologics in airway disorders, and highlights the need for continued research and improvement in access to these effective treatments.

Meta Tag

Category Allergy and Airway

Speaker Diego Maselli Caceres, MD, FCCP

Speaker Nicola Hanania, MD, MS, FCCP

Speaker Muhammad Adrish, MD, MBA, FCCP

Speaker Njira Lugogo, MD

Speaker Meredith Turetz, MD

Keywords

biologics

airway disorders

asthma

eligibility criteria

effectiveness

safety

eosinophil levels

research